Plain-English translation of NCT06824974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a feasibility study testing whether a lifestyle intervention combining time-restricted eating (stopping food intake by 7 PM and fasting for 14-16 hours overnight) and a healthy diet can be safely adopted by adults with metabolic liver disease or early-stage liver cancer. Researchers want to understand whether this eating pattern is practical for patients to follow, safe to try, and whether it improves blood markers related to metabolism, inflammation, and overall quality of life.
Many people with metabolic liver disease or liver cancer also struggle with obesity and metabolic problems. This trial explores whether time-restricted eating—a simpler dietary approach than counting calories—might help improve these conditions, reduce inflammation, and give patients better outcomes without requiring complex dietary restrictions.
You likely qualify if…
You likely don't qualify if…
If you join the intervention group, you will adopt a time-restricted eating schedule where you stop eating by 7 PM each night and fast for 14-16 hours before your next meal, while also following a healthy diet plan. If you are in the control group, you will continue your normal eating habits while providing blood samples and completing surveys. Both groups will have regular visits to the clinic for blood work, body measurements, sleep and activity tracking, quality-of-life questionnaires, and dietary assessments. The study will monitor your liver function, blood sugar levels, metabolism, and how you're feeling throughout your participation.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States